--- a
+++ b/clusters/9knumclustersv2/clust_1085.txt
@@ -0,0 +1,67 @@
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  hours of start of study treatment
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within  weeks of study entry
+Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within  hours of study entry
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of the start of treatment
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant or breastfeeding; a negative serum pregnancy test is required no more than  days before study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative urine pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have two negative pregnancy tests; the first test should be performed within - days of study entry, and the second test within  hours prior to prescribing pomalidomide
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of signing consent
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  hours of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within  hours of study entry
+Pregnant or nursing; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within  days of study entry.
+Pregnant or breastfeeding; a negative serum pregnancy test is required no more than  days before study entry
+Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within  days of study entry (Arm B)
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of start of study treatment
+Pregnant or breastfeeding; a negative serum pregnancy test is required no more than  days before study entry
+Pregnant and/or breastfeeding; patients of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within  days of study entry if premenopausal
+Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within  hours of study entry
+Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within  days of study entry and again within  hours prior to first treatment.
+Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within  days of first dose of vaccine.
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Female patients who are pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within  days of study entry
+Pregnant or breastfeeding, or intending to become pregnant during the study; women of childbearing potential must have a negative serum pregnancy test result within  days prior to initiation of study treatment
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of first dose of vaccine
+Pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patients of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patients that are of childbearing age must have a negative pregnancy test at screening and agree on using contraception during the duration of the study
+Pregnant and/or breastfeeding: patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of initiation of treatment
+Pregnant or breastfeeding patients; women of childbearing potential must have a documented negative pregnancy test a maximum of  days before start of treatment
+Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within  days of study entry
+Patient must not be pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within  days of study entry
+Pregnant or breastfeeding; a negative pregnancy test is required within  days of randomization for all women of childbearing potential
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding women; women of childbearing potential must have a negative serum pregnancy test within  days of study entry
+Patient must not be pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within seven days of study entry
+Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within  hours of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; patient must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within  days of study entry
+Pregnant and/or breastfeeding; female patients must have a negative urine pregnancy test within  days of study entry
+Breastfeeding or pregnant; serum pregnancy test will be conducted